Rising Secondary Leukemia Risk: The Hidden Cost of Long-Term Cancer Treatment
Researchers have identified a novel peptide capable of inhibiting DNA double-strand breaks, a primary mechanism behind treatment-induced secondary leukemias. By stabilizing genomic integrity during chemotherapy or radiation, this intervention offers ... Read More